In the pharmaceutical industry, specialised translation is a critical factor for safety, regulatory compliance and international trust.
Translation is decisive for medical device companies because it connects safe use, regulatory compliance, market entry timelines and document control.
Machine translation post-editing makes it possible to speed up B2B translations in regulated sectors, but it is only safe when it combines technology, specialised human review and certified processes.
Localisation of medical or technical content is not a formatting task; it is a risk-management process.
